SCHEMBL6500647

SCHEMBL6500647

Cc1ccc(C(C=O)c2ccncc2)cc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
TP53 P04637 1/20 0.33
CYP19A1 P11511 1/20 0.32
ROCK2 O75116 1/20 0.32
CHEK2 O96017 1/20 0.32
PRKACA P17612 1/20 0.32
RPS6KB1 P23443 1/20 0.32
AKT1 P31749 1/20 0.32
MATK P42679 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
RPS6KA3 P51812 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499118 0.85 CYP17A1 (0.37) CYP3A4CYP2C19CYP19A1AKT1GSK3B
SCHEMBL6504970 0.82 CYP19A1 (0.39) NPC1RAB9ACYP3A4CYP2C19HTT
SCHEMBL6499767 0.79 CYP3A4 (0.35) NPC1RAB9ACYP3A4CYP2C19HTT
SCHEMBL6510105 0.78 MAPKAPK2 (0.44) NPC1RAB9APKMCYP19A1ROCK2
SCHEMBL6508159 0.76 ALDH1A1 (0.47) CYP2C19PKM
SCHEMBL6410479 0.75 SLC6A2 (0.46) NPC1RAB9ACYP3A4ROCK2
SCHEMBL2789136 0.74 LTA4H (0.42) RAB9ACYP19A1
SCHEMBL5184111 0.74 CYP19A1 (0.61) MAPK1CYP19A1AKT1
SCHEMBL8309987 0.74 LMNA (0.42) NPC1RAB9ACYP3A4CYP2C19CYP19A1
SCHEMBL5319843 0.74 CYP17A1 (0.53) NPC1RAB9ACYP3A4CYP2C19MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 NPC1 1275/4885RAB9A 958/4885CCNC 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.